MD742C2 - Regenerative remedy - Google Patents

Regenerative remedy

Info

Publication number
MD742C2
MD742C2 MD95-0411A MD950411A MD742C2 MD 742 C2 MD742 C2 MD 742C2 MD 950411 A MD950411 A MD 950411A MD 742 C2 MD742 C2 MD 742C2
Authority
MD
Moldova
Prior art keywords
remedy
regenerative
globulin
invention consists
dry concentrate
Prior art date
Application number
MD95-0411A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD742B1 (en
Inventor
Ion Grudzitchii
Original Assignee
Ion Grudzitchii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ion Grudzitchii filed Critical Ion Grudzitchii
Priority to MD95-0411A priority Critical patent/MD742C2/en
Publication of MD742B1 publication Critical patent/MD742B1/en
Publication of MD742C2 publication Critical patent/MD742C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to the medicine, especially to a regenerative remedy.The summary of the invention consists in the fact, that the proposed remedy contains as an active principle the α-β globulin donor blood plasma dry concentrate and the 85% aqueous glycerol with the following ingredient content: 5-10% of the α-β globulin dry concentrate and the 85% aqueous glycerol - the rest.The technical result of the invention consists in the remedy regenerative activity increase and expansion of the application spectrum thereof.
MD95-0411A 1995-11-16 1995-11-16 Regenerative remedy MD742C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD95-0411A MD742C2 (en) 1995-11-16 1995-11-16 Regenerative remedy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD95-0411A MD742C2 (en) 1995-11-16 1995-11-16 Regenerative remedy

Publications (2)

Publication Number Publication Date
MD742B1 MD742B1 (en) 1997-06-30
MD742C2 true MD742C2 (en) 1998-02-28

Family

ID=19738754

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0411A MD742C2 (en) 1995-11-16 1995-11-16 Regenerative remedy

Country Status (1)

Country Link
MD (1) MD742C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1179Z (en) * 2017-03-29 2018-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating trophic ulcers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU724141A1 (en) * 1977-07-04 1980-03-30 Ростовский государственный медицинский институт Agent for treating trophic ulcers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU724141A1 (en) * 1977-07-04 1980-03-30 Ростовский государственный медицинский институт Agent for treating trophic ulcers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Препараты крови. Инструктивно-методические материалы по контролю и производству" под редакцией С.П. Буренкова, 1976 г., М., с. 333-338. *

Also Published As

Publication number Publication date
MD742B1 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
GT199800126A (en) COMBINATION THERAPY.
NO990916D0 (en) Use of GLP-1 or analogues in the treatment of myocardial infarction
BR9913932A (en) Use of glp-1 analogs in the treatment of stroke
CA2169091A1 (en) Silicone Grafted Thermoplastic Elastomeric Copolymers and Hair and Skin Care Compositions Containing the Same
FI920026A0 (en) PHARMACEUTICAL COMPOSITION ANVAENDBAR SOM AVMAGRINGSMEDICIN.
ES2040232T3 (en) MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA.
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
ES2040727T3 (en) A PROCESS TO PREPARE A FORMULATION IN AEROSOL IN SOLUTION OF AN ANALOG.
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
ATE234082T1 (en) MEDICINAL PRODUCT CONTAINING ADENOSINE
SE9300971D0 (en) HUDVAARDSKOMPOSITION
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
MD742C2 (en) Regenerative remedy
CA2286378A1 (en) Composition based on plant and essential oil extracts, usable in therapy, cosmetics and dietetics
IL96903A0 (en) Topical pharmaceutical compositions comprising a vitamin d3 derivative
MD980129A (en) Antiherpetic remedy
MD1051C2 (en) Antiherpetic remedy
MD916G2 (en) Ungent for stomatologic deseases treatment
ATE203903T1 (en) DELTA-AMINOLEVULIC ACID CONTAINING MEDICINAL PRODUCT
NO980175L (en) Use of cationic biopolymers to prepare anti-dandruff agents
WO1996032133A3 (en) Conjugate for treating inflammatory, infectious and/or skin diseases
OA09771A (en) Asphodelus composition for increasing white blood cell count.
KR950007852A (en) Arthritis treatment containing uracil as an active ingredient

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20151116